BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 38701304)

  • 1. Racial and ethnic disparities related to the Medicare Part D Medication Therapy Management Program.
    Allen A; Hung A
    J Manag Care Spec Pharm; 2024 Jun; 30(6):609-616. PubMed ID: 38824629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Medication Review Completion Rates and Disparities After Medicare Star Rating Measure.
    Hung A; Wilson L; Smith VA; Pavon JM; Sloan CE; Hastings SN; Farley J; Maciejewski ML
    JAMA Health Forum; 2024 May; 5(5):e240807. PubMed ID: 38700854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of comprehensive medication reviews on potentially inappropriate medication discontinuation in Medicare beneficiaries.
    Hung A; Wilson LE; Smith VA; Pavon JM; Sloan CE; Hastings SN; Maciejewski ML
    J Am Geriatr Soc; 2024 Jun; ():. PubMed ID: 38826070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare Medication Therapy Management: beneficiary characteristics and utilization patterns in a national CMS Medicare fee-for-service sample (2013-2016).
    Oyarzún-González X; Abner EL; Freeman P; Kucharska-Newton A; Fardo DW; Moga DC
    J Am Pharm Assoc (2003); 2024 May; ():102140. PubMed ID: 38825153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Medicare Part D on Racial and Ethnic Minorities.
    Jamison JJ; Wang J; Surbhi S; Adams S; Solomon D; Hohmeier KC; McDonough S; Eoff JC
    Divers Equal Health Care; 2016; 13(5):326-333. PubMed ID: 28008353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicare Part D and quality of prescription medication use in older adults.
    Lau DT; Briesacher BA; Touchette DR; Stubbings J; Ng JH
    Drugs Aging; 2011 Oct; 28(10):797-807. PubMed ID: 21970307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of medication therapy management among Medicare population and across racial/ethnic groups.
    Tsang CCS; Wang J; Shih YT
    Medicine (Baltimore); 2024 May; 103(18):e37935. PubMed ID: 38701304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.
    Wang J; Qiao Y; Shih YC; Jarrett-Jamison J; Spivey CA; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2015 Nov; 21(11):993-1003. PubMed ID: 26521111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.
    Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential health implications of racial and ethnic disparities in meeting MTM eligibility criteria.
    Wang J; Qiao Y; Tina Shih YC; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC
    Res Social Adm Pharm; 2014; 10(1):106-25. PubMed ID: 23759673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial/ethnic disparities in the enrollment of Medication Therapy Management programs among Medicare beneficiaries with Alzheimer's disease and related dementias.
    Browning JA; Tsang CCS; Zeng R; Dong X; Garuccio J; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Wang J
    Curr Med Res Opin; 2022 Oct; 38(10):1715-1725. PubMed ID: 35852087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of Medication Therapy Management Program Across Racial and Ethnic Groups Among Medicare Beneficiaries.
    Tsang CCS; Shih YT; Dong X; Garuccio J; Browning JA; Wan JY; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Zeng R; Wang J
    Value Health; 2023 May; 26(5):649-657. PubMed ID: 36376143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with medication nonadherence among Medicare low-income subsidy beneficiaries with diabetes, hypertension, and/or heart failure.
    Steve Tsang CC; Browning J; Todor L; Dougherty S; Hohmeier KC; Sam Li M; Borja-Hart N; Hines LE; Wang J
    J Manag Care Spec Pharm; 2021 Aug; 27(8):971-981. PubMed ID: 34337985
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.